Abstract
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Issue: Mar/Apr 2021 - Volume 25, Number 2
Page(s): 115-124
Abstract
The United States Pharmacopeial Convention, Inc. recommends within the standards of the United States Pharmacopeia that compounding pharmacies have staff dedicated to quality assurance and quality control to ensure patients are receiving safe medications. The quality-control program must include testing. While compounding pharmacies have grown familiar with potency, sterility, and endotoxin testing, there are many more tests recommended within the United States Pharmacopeia that are critical for evaluating the quality of compounded preparations. This article discusses when a few of these tests should be utilized, how to assign acceptance criteria, and how test results are obtained.
Related Keywords
Related Categories
Related Articles from IJPC
| Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
|---|---|
|
Mar/Apr 2021
Pg. 115-124
|
|
|
Mar/Apr 2020
Pg. 92
|
|
|
May/Jun 2020
Pg. 180
|
|
|
Mar/Apr 2012
Pg. 146-150
|
|
|
Nov/Dec 2021
Pg. 491-496
|
|
|
Sep/Oct 2007
Pg. 400-403
|
|
|
Jan/Feb 2012
Pg. 64-68
|
|
|
Jul/Aug 2013
Pg. 283-288
|
|
|
Mar/Apr 2014
Pg. 123-130
|
|
|
May/Jun 2017
Pg. 180
|
|
|
Jul/Aug 2007
Pg. 302-305
|
|
|
Sep/Oct 2007
Pg. 404-410
|
|
|
Jul/Aug 2001
Pg. 265-267
|
|
|
Sep/Oct 2013
Pg. 439
|
|
|
Jul/Aug 2011
Pg. 328-331
|
|
|
Nov/Dec 2011
Pg. 488-496
|
|
|
Sep/Oct 2011
Pg. 408-414
|
|
|
Jan/Feb 2012
Pg. 6-10
|
|
|
May/Jun 2008
Pg. 216-229
|
|
|
Jan/Feb 2020
Pg. 21-27
|